Literature DB >> 28953418

Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Milk Samples of Dairy Cows with Mastitis in Bavaria, Germany.

David Eisenberger1, Anja Carl1, Joachim Balsliemke1, Peter Kämpf2, Silke Nickel1, Gesine Schulze1, Giuseppe Valenza1,3.   

Abstract

The aim of this study was to determine the rate of extended-spectrum β-lactamase (ESBL)-producing microorganisms among Escherichia coli isolates causing bovine mastitis, including molecular characterization of these isolates. Therefore, a total of 490 bovine E. coli isolates from milk samples of dairy cows with mastitis were investigated for ESBL production by antimicrobial susceptibility testing, PCR-based detection, and sequencing of ESBL encoding genes, which were identified in 22 isolates (4.5%). Moreover, resistance to the fluoroquinolones enrofloxacin and marbofloxacin occurred in 15 of 22 ESBL-producing isolates (68.2%). All ESBL-producing isolates carried a blaCTX-M-like gene, with blaCTX-M-14 (n = 10) as the most prevalent type. Seven isolates producing CTX-M-14 and belonging to phylogenetic group A were further investigated for genetic relatedness by multilocus sequence typing. Five of them could be assigned to four different sequence types (STs): ST10 (n = 2), ST167 (n = 1), ST410 (n = 1), and ST744 (n = 1), whereas the remaining two isolates could not be assigned. To conclude, the rate of ESBL-producing E. coli associated with cattle mastitis was 4.5%. Furthermore, a high proportion of fluoroquinolone coresistance could be detected. Therefore, careful and continuous surveillance of ESBL-producing E. coli in cattle and consequent implementation of prevention measures are needed to avoid a further spread of these multidrug-resistant bacteria.

Entities:  

Keywords:  ESBL; Escherichia coli; bovine mastitis; molecular characterization; prevalence

Mesh:

Substances:

Year:  2017        PMID: 28953418     DOI: 10.1089/mdr.2017.0182

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Molecular Epidemiology of Dairy Cattle-Associated Escherichia coli Carrying blaCTX-M Genes in Washington State.

Authors:  Josephine A Afema; Sara Ahmed; Thomas E Besser; Lisa P Jones; William M Sischo; Margaret A Davis
Journal:  Appl Environ Microbiol       Date:  2018-03-01       Impact factor: 4.792

2.  Phenotyping and genotyping studies on extended-spectrum β-lactamase-producing Escherichia coli isolates from mastitic cows on dairy farms in Egypt.

Authors:  Shereen S El-Mohandes; Rasha H Eid; Ahmad M Allam; Hala A A Abou-Zeina; Mohamed K Elbayoumy
Journal:  Vet World       Date:  2022-04-11

3.  Multidrug-resistant enterobacteria in newborn dairy calves in Germany.

Authors:  Jil Waade; Uwe Seibt; Walther Honscha; Fanny Rachidi; Alexander Starke; Stephanie Speck; Uwe Truyen
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

Review 4.  Escherichia coli Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges.

Authors:  Débora Brito Goulart; Melha Mellata
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

5.  Comparative Genome Analysis of an Extensively Drug-Resistant Isolate of Avian Sequence Type 167 Escherichia coli Strain Sanji with Novel In Silico Serotype O89b:H9.

Authors:  Xiancheng Zeng; Xuelin Chi; Brian T Ho; Damee Moon; Christine Lambert; Richard J Hall; Primo Baybayan; Shihua Wang; Brenda A Wilson; Mengfei Ho
Journal:  mSystems       Date:  2019-02-26       Impact factor: 6.496

Review 6.  Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in cattle production - a threat around the world.

Authors:  Josman Dantas Palmeira; Helena Maria Neto Ferreira
Journal:  Heliyon       Date:  2020-01-30

7.  Molecular types, virulence profiles and antimicrobial resistance of Escherichia coli causing bovine mastitis.

Authors:  Magdalena Nüesch-Inderbinen; Nadine Käppeli; Marina Morach; Corinne Eicher; Sabrina Corti; Roger Stephan
Journal:  Vet Rec Open       Date:  2019-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.